BlackRock Fund Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $30.7M | Buy |
2,034,263
+939,045
| +86% | +$14.2M | 0.01% | 1956 |
|
|
2016
Q3 | $16.7M | Buy |
1,095,218
+52,118
| +5% | +$794K | ﹤0.01% | 2169 |
|
|
2016
Q2 | $40.5M | Buy |
1,043,100
+72,160
| +7% | +$2.8M | 0.01% | 1631 |
|
|
2016
Q1 | $27M | Buy |
970,940
+24,482
| +3% | +$681K | 0.01% | 1817 |
|
|
2015
Q4 | $50.9M | Buy |
946,458
+59,661
| +7% | +$3.21M | 0.01% | 1454 |
|
|
2015
Q3 | $35.5M | Sell |
886,797
-104,989
| -11% | -$4.2M | 0.01% | 1635 |
|
|
2015
Q2 | $31.7M | Buy |
991,786
+14,840
| +2% | +$474K | 0.01% | 1820 |
|
|
2015
Q1 | $23.3M | Buy |
976,946
+498,212
| +104% | +$11.9M | 0.01% | 1986 |
|
|
2014
Q4 | $8.45M | Buy |
478,734
+73,388
| +18% | +$1.3M | ﹤0.01% | 2559 |
|
|
2014
Q3 | $5.56M | Sell |
405,346
-16,647
| -4% | -$228K | ﹤0.01% | 2686 |
|
|
2014
Q2 | $7.12M | Buy |
+421,993
| New | +$7.12M | ﹤0.01% | 2623 |
|